Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$242.09
2.691.12%
À la fermeture: -
$242.38
0.290.12%
Après les heures de négociation: 7:58 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
International Business Machines Corp a un objectif de cours consensus de $236.48, basé sur les évaluations des 22 analystes. Le plus élevé est de $325 attribué par Wedbush le juin 20, 2025, et le plus bas est de $140 attribué par MoffettNathanson le janvier 19, 2023. Les 3 dernières évaluations d'analystes ont été publiées par UBS, JP Morgan et B of A Securities le juillet 24, 2025. Avec un objectif de cours moyen de $266.67 entre UBS, JP Morgan et B of A Securities, il y a une variation implicite de 10.02% upside pour International Business Machines Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
JP Morgan
B of A Securities
BMO Capital
RBC Capital
1calculé à partir des notes des analystes
Notes d'analystes pour IBM
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/24/2025 | -17.48% | UBS | $195 → $200 | Maintains | Sell | |||
07/24/2025 | 19.65% | JP Morgan | $244 → $290 | Maintains | Neutral | |||
07/24/2025 | 27.9% | B of A Securities | $320 → $310 | Maintains | Buy | |||
07/18/2025 | 23.77% | BMO Capital | $260 → $300 | Maintains | Market Perform | |||
07/17/2025 | 29.96% | RBC Capital | $285 → $315 | Maintains | Outperform | |||
07/16/2025 | 27.9% | Stifel | $290 → $310 | Maintains | Buy | |||
07/09/2025 | -19.55% | UBS | $170 → $195 | Maintains | Sell | |||
07/02/2025 | 27.9% | Goldman Sachs | $270 → $310 | Maintains | Buy | |||
06/20/2025 | 34.09% | Wedbush | $300 → $325 | Maintains | Outperform | |||
06/18/2025 | 32.02% | B of A Securities | $290 → $320 | Maintains | Buy | |||
06/09/2025 | 19.65% | B of A Securities | $270 → $290 | Maintains | Buy | |||
05/15/2025 | 17.58% | RBC Capital | $276 → $285 | Maintains | Outperform | |||
05/07/2025 | 23.77% | Wedbush | $300 → $300 | Reiterates | Outperform → Outperform | |||
04/24/2025 | -29.86% | UBS | $160 → $170 | Maintains | Sell | |||
04/24/2025 | -3.87% | Morgan Stanley | $237 → $233 | Maintains | Equal-Weight | |||
04/24/2025 | 23.77% | Wedbush | $300 → $300 | Reiterates | Outperform → Outperform | |||
04/14/2025 | 13.87% | RBC Capital | $276 → $276 | Reiterates | Outperform → Outperform | |||
03/31/2025 | 9.33% | Jefferies | $270 → $265 | Maintains | Hold | |||
02/11/2025 | 32.02% | Oppenheimer | → $320 | Initiates | → Outperform | |||
01/30/2025 | 0.67% | JP Morgan | $233 → $244 | Maintains | Neutral | |||
01/30/2025 | 11.4% | Jefferies | $245 → $270 | Maintains | Hold | |||
01/30/2025 | 11.4% | B of A Securities | $260 → $270 | Maintains | Buy | |||
01/30/2025 | 15.52% | BMO Capital | $260 → $280 | Maintains | Market Perform | |||
01/30/2025 | 13.87% | RBC Capital | $250 → $276 | Maintains | Outperform | |||
01/30/2025 | -5.93% | Morgan Stanley | $217 → $228 | Maintains | Equal-Weight | |||
01/28/2025 | -10.47% | Morgan Stanley | $222 → $217 | Maintains | Equal-Weight | |||
01/27/2025 | 3.14% | RBC Capital | $250 → $250 | Reiterates | Outperform → Outperform | |||
01/23/2025 | -3.87% | JP Morgan | $227 → $233 | Maintains | Neutral | |||
01/23/2025 | 7.27% | B of A Securities | $250 → $260 | Maintains | Buy | |||
01/14/2025 | -33.99% | UBS | $150 → $160 | Maintains | Sell | |||
01/03/2025 | -11.3% | Bernstein | $210 → $215 | Maintains | Market Perform | |||
12/16/2024 | -8.41% | Morgan Stanley | $208 → $222 | Maintains | Equal-Weight | |||
10/24/2024 | 3.14% | RBC Capital | $250 → $250 | Reiterates | Outperform → Outperform | |||
10/24/2024 | -14.18% | Morgan Stanley | $217 → $208 | Maintains | Equal-Weight | |||
10/24/2024 | 7.27% | BMO Capital | $235 → $260 | Maintains | Market Perform | |||
10/21/2024 | 1.08% | Jefferies | $200 → $245 | Maintains | Hold | |||
10/17/2024 | -10.47% | Morgan Stanley | $182 → $217 | Maintains | Equal-Weight | |||
10/16/2024 | 1.49% | Stifel | $205 → $246 | Maintains | Buy | |||
10/10/2024 | 3.14% | RBC Capital | $211 → $250 | Maintains | Outperform | |||
10/09/2024 | 3.14% | B of A Securities | $209 → $250 | Maintains | Buy | |||
09/30/2024 | 3.14% | Goldman Sachs | $220 → $250 | Maintains | Buy | |||
09/11/2024 | -0.98% | Evercore ISI Group | $215 → $240 | Maintains | Outperform | |||
09/04/2024 | -40.18% | UBS | $130 → $145 | Maintains | Sell | |||
07/25/2024 | -12.95% | RBC Capital | $200 → $211 | Maintains | Outperform | |||
07/25/2024 | -17.48% | Jefferies | $190 → $200 | Maintains | Hold | |||
07/25/2024 | -13.36% | BMO Capital | $190 → $210 | Maintains | Market Perform | |||
07/25/2024 | -15.42% | Stifel | $190 → $205 | Maintains | Buy | |||
06/24/2024 | -17.48% | Goldman Sachs | → $200 | Initiates | → Buy | |||
05/22/2024 | -17.48% | RBC Capital | $200 → $200 | Reiterates | Outperform → Outperform | |||
05/16/2024 | -17.48% | RBC Capital | $200 → $200 | Reiterates | Outperform → Outperform | |||
05/16/2024 | -21.61% | Stifel | $190 → $190 | Maintains | Buy | |||
05/02/2024 | -40.18% | Exane BNP Paribas | → $145 | Initiates | → Underperform | |||
04/26/2024 | -26.15% | Morgan Stanley | $186 → $179 | Maintains | Equal-Weight | |||
04/25/2024 | -23.67% | JP Morgan | $190 → $185 | Maintains | Neutral | |||
04/25/2024 | -21.61% | BMO Capital | $210 → $190 | Maintains | Market Perform | |||
04/25/2024 | -33.99% | Wedbush | $140 → $160 | Maintains | Neutral | |||
04/25/2024 | -21.61% | Jefferies | $210 → $190 | Maintains | Hold | |||
04/23/2024 | -13.36% | Jefferies | $215 → $210 | Maintains | Hold | |||
04/22/2024 | -46.37% | UBS | $125 → $130 | Maintains | Sell | |||
04/17/2024 | -21.61% | Stifel | $190 → $190 | Maintains | Buy | |||
03/14/2024 | -9.23% | B of A Securities | $200 → $220 | Maintains | Buy | |||
03/07/2024 | -23.26% | Bernstein | $165 → $186 | Maintains | Market Perform | |||
01/25/2024 | -17.48% | RBC Capital | $179 → $200 | Maintains | Outperform | |||
01/25/2024 | -13.36% | BMO Capital | $155 → $210 | Maintains | Market Perform | |||
01/25/2024 | -21.61% | Stifel | $183 → $190 | Maintains | Buy | |||
01/22/2024 | -24.5% | Stifel | $144 → $183 | Maintains | Buy | |||
01/19/2024 | -17.48% | Evercore ISI Group | $165 → $200 | Upgrade | In-Line → Outperform | |||
01/05/2024 | -25.74% | Jefferies | → $180 | Initiates | → Hold | |||
01/05/2024 | -41% | Societe Generale | → $143 | Downgrade | Hold → Sell | |||
11/13/2023 | -42.24% | Wedbush | → $140 | Reiterates | Neutral → Neutral | |||
10/26/2023 | -26.15% | RBC Capital | $188 → $179 | Maintains | Outperform | |||
10/26/2023 | -36.05% | BMO Capital | $152 → $155 | Maintains | Market Perform | |||
10/26/2023 | -42.24% | Wedbush | → $140 | Reiterates | Neutral → Neutral | |||
10/17/2023 | -46.37% | Morgan Stanley | $135 → $130 | Maintains | Equal-Weight | |||
09/20/2023 | -22.44% | RBC Capital | → $188 | Initiates | → Outperform | |||
07/20/2023 | -33.99% | B of A Securities | $152 → $160 | Maintains | Buy | |||
07/20/2023 | -40.59% | Stifel | $140 → $144 | Maintains | Buy | |||
07/20/2023 | -44.3% | Morgan Stanley | $135 → $135 | Reiterates | Equal-Weight → Equal-Weight | |||
07/20/2023 | -42.24% | Wedbush | → $140 | Reiterates | Neutral → Neutral | |||
07/20/2023 | -37.29% | BMO Capital | $150 → $152 | Maintains | Market Perform | |||
07/17/2023 | -38.11% | BMO Capital | $145 → $150 | Maintains | Market Perform | |||
07/12/2023 | -44.3% | Morgan Stanley | $135 → $135 | Reiterates | Equal-Weight → Equal-Weight | |||
07/11/2023 | -33.16% | Credit Suisse | → $162 | Reiterates | Outperform → Outperform | |||
07/07/2023 | -40.18% | JP Morgan | → $145 | Initiates | → Neutral | |||
06/26/2023 | -33.16% | Credit Suisse | $162 → $162 | Reiterates | Outperform → Outperform | |||
04/27/2023 | -42.24% | Wedbush | → $140 | Reiterates | → Neutral | |||
04/20/2023 | -40.18% | BMO Capital | $155 → $145 | Maintains | Market Perform | |||
04/20/2023 | -42.24% | Evercore ISI Group | $150 → $140 | Maintains | In-Line | |||
04/20/2023 | -42.24% | Stifel | $150 → $140 | Maintains | Buy | |||
04/20/2023 | -44.3% | Morgan Stanley | $143 → $135 | Maintains | Equal-Weight | |||
04/13/2023 | -33.16% | Credit Suisse | $165 → $162 | Maintains | Outperform | |||
02/06/2023 | — | Edward Jones | — | Downgrade | Buy → Hold | |||
01/26/2023 | -40.18% | Citigroup | $140 → $145 | Maintains | Neutral | |||
01/26/2023 | -36.05% | BMO Capital | $148 → $155 | Maintains | Market Perform | |||
01/23/2023 | -34.81% | Stifel | $140 → $158 | Maintains | Buy | |||
01/19/2023 | -42.24% | MoffettNathanson | → $140 | Upgrade | Underperform → Market Perform | |||
01/18/2023 | -38.94% | Morgan Stanley | $152 → $148 | Downgrade | Overweight → Equal-Weight | |||
10/20/2022 | -36.05% | Credit Suisse | $158 → $155 | Maintains | Outperform | |||
10/17/2022 | -42.24% | Stifel | $150 → $140 | Maintains | Buy | |||
10/06/2022 | -37.29% | Morgan Stanley | $155 → $152 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action IBM (IBM) ?
Le dernier objectif de prix pour IBM (NYSE:IBM) a été rapporté par UBS le juillet 24, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $200.00 s'attendant à ce que IBM se fall dans les 12 prochains mois (un possible changement de -17.48% downside). 43 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour IBM (IBM) ?
La dernière note d'analyste pour IBM (NYSE:IBM) a été fournie par UBS, et IBM maintenu leur note sell.
Quand a eu lieu la dernière mise à niveau pour IBM (IBM) ?
La dernière amélioration pour International Business Machines Corp a eu lieu le janvier 19, 2024 lorsque Evercore ISI Group a augmenté leur objectif de prix à $200. Evercore ISI Group avait précédemment an in-line pour International Business Machines Corp.
Quand a eu lieu la dernière dégradation pour IBM (IBM) ?
La dernière réduction pour International Business Machines Corp a eu lieu le janvier 5, 2024 lorsque Societe Generale a changé leur objectif de prix de N/A à $143 pour International Business Machines Corp.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour IBM (IBM) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de IBM, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour IBM a été déposée le juillet 24, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers juillet 24, 2026.
La note d'analyste pour IBM (IBM) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de IBM (IBM) était un maintenu avec un objectif de prix de $195.00 à $200.00. Le prix actuel de IBM (IBM) est de $242.38, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.